For a UK laboratory comparing research peptide suppliers, a useful shortlist starts with evidence that can be checked. This guide sets out our proposed procurement questions. It does not rank suppliers, certify the brands in our preview catalogue or treat a UK address as proof of product quality.
At a glance
- Separate company location, manufacture, testing and dispatch.
- Ask for documentation tied to the exact product and batch.
- Treat research-use wording as a statement to examine, not a blanket regulatory clearance.
Define the laboratory requirement first
Write down the material your project actually needs: the sequence or identity, required presentation, relevant analytical attributes and the documentation your institution expects. Only then compare listings. Similar compound names can hide differences that matter to a purchasing decision.
Use the same question set for every candidate. If a supplier has not published an answer, record it as unknown and request it. A long specification page is useful only when its details can be matched to the product on offer.
Be precise about the UK connection
Company registration, manufacturing location, analytical laboratory and dispatch point are separate fields in our checklist. Companies House provides a way to look up filed company information, but the register also warns that it does not check the accuracy of information filed. A registry entry alone is therefore not evidence of a product’s manufacturing origin or analytical quality.
Ask where the actual order will be dispatched from and who is responsible for delivery problems. Do not infer that a GBP price or UK contact address settles those questions.
Make batch evidence part of the comparison
Request the original analysis document and the identifiers needed to connect it to the offered batch. Use our COA guide to organise the review. If a laboratory accreditation claim is relevant, ask for the applicable activity and scope. UKAS distinguishes fixed and flexible scopes; a general laboratory badge should not replace that check.
Keep the evidence and unanswered questions alongside the quote. This prevents a low headline price from obscuring missing specifications, an unresolved report association or an unsuitable dispatch arrangement.
Read the whole product presentation
Current MHRA guidance explains that medicinal-product assessment considers claims, ingredients and their properties, intended purpose and how a product is presented. Our reading is that a research-use label should not be treated as a shortcut around examining that wider context.
If the intended work or a supplier’s claims raise a classification question, obtain appropriate institutional or regulatory advice before procurement. This article does not give a universal ruling on the legality of buying, selling or using a particular peptide.
A comparison sheet worth keeping
| Question | Evidence to request |
|---|---|
| Who is supplying it? | Business identity and a contact responsible for the order |
| What is the material? | Exact identity, presentation and written specification |
| Which batch? | Product-matched lot and original analytical report |
| What was tested? | Methods, results and relevant laboratory scope |
| How will it arrive? | Dispatch location, packaging and delivery-deviation process |
| What remains unresolved? | A clear request list and the person responsible for review |
How Selective Peptides approaches the shortlist
Our aim is to make the supplier-selection work easier by bringing product records and source documents into one place. The current preview marks supplier approval, missing information and document questions explicitly. Inclusion in that preview is not a completed quality endorsement.
Use the catalogue to inspect specifications and the report tree to identify what still needs to be requested. A responsible shortlist can remain selective while being transparent about the work that is still outstanding.
Questions answered
Does UK dispatch prove UK manufacture?
No. Ask the supplier to document manufacturing origin and dispatch location separately.
Does the Institute endorse every listed brand?
No. Preview entries and supplier documents remain subject to review. Approval must be supported by completed checks and relevant batch evidence.
Sources & further reading
Source record assembled for this editorial on 25 October 2026. Research dates are shown separately from our publication date. Live trial status and supplier information may change.
- Search the UK company register ↗Companies House
- Scope of laboratory accreditation ↗United Kingdom Accreditation Service
- Borderline products: medicinal-product assessment ↗MHRA · Updated 2 July 2026
Independent, source-based editorial. No clinical review or affiliation with the cited research institutions is claimed.
Read our editorial approach ↗